TY - JOUR T1 - Additional safety consideration for azithromycin in the management of SARS-CoV-2 infection JF - Canadian Medical Association Journal JO - CMAJ SP - E483 LP - E483 DO - 10.1503/cmaj.75427 VL - 192 IS - 18 AU - Matthew D. Seftel Y1 - 2020/05/04 UR - http://www.cmaj.ca/content/192/18/E483.abstract ER -